miscsubjectsAI governance
Evidence review

TB-500 for GLP-1 Gut Damage and Gastroparesis: What the Evidence Shows

· · 4 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tb-500-glp1-gut`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tb-500-glp1-gut

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-glp1-gut/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-glp1-gut/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-glp1-gut/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-glp1-gut/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have GLP-1 gut damage / gastroparesis

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: TB-500 (thymosin beta-4) is studied for repair-cell migration and actin regulation — cells that need to reach an injury and rebuild structure. That is regeneration: move repair machinery to the damage.

Why TB-500 might help you

  1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.
  2. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
  3. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.
  4. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.

Why GLP-1 agonists (class) matters for you

  1. Drug: GLP-1 agonists (class)
  2. What it does: Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • TB-500 → inflammation clearance / repair-cell migration

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.37 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review (source s10)

2026 scoping review mapping 80 studies; confirms limited human data outside skin/eye and absence of gut-specific trials.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

GLP-1 receptor agonists and delayed gastric emptying (source s0)

Review of mechanisms linking GLP-1 agonism to gastroparesis symptoms in humans.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide (source s1)

Documents human clinical consequences of motility slowing.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

How many of you have experienced permanent intestinal... — Reddit, r/Peptides (source s29)

Example of GLP-1 gut discussion on Reddit with limited peptide specificity.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

GLP-1 agonists · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedTB-500: Thymosin Beta-4 · 14 humanAging Repair Stack: BPC-157 + TB-500 + GHK-Cu · 12 humanRecovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290 · 7 humanTB-500 for Benzodiazepine Withdrawal: Evidence-Graded Review · 2 human
Evidence · 5 sources · swipe →chain ff15e639b1dd · verify chain · provenance
1 / 5
Evidence ledger 4 · tier-ranked · API
humanlow confidence
GLP-1 agonists reproducibly delay gastric emptying in humans as a class effect.
sources: s0, s1, s3
humanlow confidence
No human trials exist for TB-500 or thymosin beta-4 in gastroparesis or GLP-1 gut damage.
sources: s10
preclinicallow confidence
Thymosin beta-4 / TB-500 evidence is largely preclinical with human data limited to wound/skin and ocular contexts.
sources: s10
anecdotallow confidence
Reddit users discuss TB-500 mainly in general recovery stacks rather than specific GLP-1 gastroparesis reversal.
sources: s29
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:38
TB-500 for GLP-1 Gut Damage and Gastroparesis: What the Evidence Shows · 4 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: TB 500 for Glp1 Gut
Slug: tb-500-glp1-gut
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"GLP-1 gut damage / gastroparesis","condition_key":"glp1-gut-damage","primary_peptide":"tb-500","peptides_in_scope":[{"id":"tb-500","name":"TB-500"}],"drugs_in_scope":["glp1-agonists"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":
it output
{
  "slug": "tb-500-glp1-gut",
  "title": "TB-500 for GLP-1 Gut Damage and Gastroparesis: What the Evidence Shows",
  "body": "## What's breaking down if you have GLP-1 gut damage / gastroparesis\n\nGLP-1 receptor agonists slow gastric emptying as part of their intended action on gut motility. In some people this effect becomes pronounced and persistent, producing symptoms that overlap with gastroparesis. The core issue is delayed stomach emptying that can lead to nausea, bloating, early satiety, and in rarer cases more serious motility problems.\n\nRepair-versus-degeneration framing applies here. The drug suppresses a motility signal to achieve metabolic benefits. When that suppression outruns the gut's ability to maintain normal function or recover normal motility, the problem persists. No direct tissue destruction occurs in most cases, but prolonged slowed transit can stress the enteric nervous system and smooth muscle layers that coordinate emptying.\n\n## Why TB-500 might help you\n\n1. You are reading about GLP-1 gut damage / gastroparesis — what breaks down matters before any compound name.\n2. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. Therefore for you: If that layer is part of y
7c6b5f988e0b4933
Machine verification: /api/articles/tb-500-glp1-gut/contributions

Related articles

GLP-1 agonists · drug map

Open evidence map →
Aging Repair Stack: BPC-157 + TB-500 + GHK-Cuaging-stack-introRecovery Stack for Complex Injuries: BPC-157 + TB-500 + ARA-290recovery-stack-introTB-500: Thymosin Beta-4tb-500TB-500 for Benzodiazepine Withdrawal: Evidence-Graded Reviewtb-500-benzo-withdrawalTB-500 and Benzodiazepines: Repair Pathways vs GABA Suppressiontb-500-benzodiazepinesTB-500 and Statin-Associated Cognitive Effects: Repair Pathways and Ev…tb-500-brain-fog
Ask this article · 7 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "GLP-1 agonists reproducibly delay gastric emptying in humans as a class effect."?
ask tb-500-glp1-gut claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials exist for TB-500 or thymosin beta-4 in gastroparesis or GLP-1 gut damage."?
ask tb-500-glp1-gut claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Thymosin beta-4 / TB-500 evidence is largely preclinical with human data limited to wound/skin and ocular contexts."?
ask tb-500-glp1-gut claim c1 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users discuss TB-500 mainly in general recovery stacks rather than specific GLP-1 gastroparesis reversal."?
ask tb-500-glp1-gut claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Example of GLP-1 gut discussion on Reddit with limited peptide specificity."
ask tb-500-glp1-gut source s29 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about TB-500 for GLP-1 Gut Damage and Gastroparesis: What the Evidence Shows — and what would you need me to tell you first?
ask tb-500-glp1-gut condition gaps · paste includes §SELF
What good and bad outcomes are documented for TB-500 for GLP-1 Gut Damage and Gastroparesis: What the Evidence Shows (studies vs anecdotes)?
ask tb-500-glp1-gut good bad experiences · paste includes §SELF
tb-500-glp1-gut · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 21770 tokens · $0 · 2 models
chain head 1892f9fd7861c5fb
write grok/grok-4.3 · 2026-06-29 23:38 · 21770 tok · 091708dfeee7
voxel_divide owner · 2026-07-17 02:42 · 0 tok · 1892f9fd7861
verify chain →
Live ledger · 3 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-21 15:22
PROTOCOL_RUN dispatch · 2026-06-29 23:38 · t_mfywhs2c
PROTOCOL_RUN dispatch · 2026-06-29 23:38 · t_mfywhs2c
view full ledger & cards →
REST + ledger
read GET /api/articles/tb-500-glp1-gut · GET /api/articles/tb-500-glp1-gut?format=post (the editable body)
create/replace POST /api/articles/tb-500-glp1-gut · PUT /api/articles/tb-500-glp1-gut (replace, keeps revision) · PATCH /api/articles/tb-500-glp1-gut (merge)
delete DELETE /api/articles/tb-500-glp1-gut
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/tb-500-glp1-gut/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/tb-500-glp1-gut/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim tb-500-glp1-gut|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…